Trending...
- Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
- Operational Agility in High Demand: FOCUS Expands to Serve a Changing Insurance Market
- From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
TAMPA, Fla. - ncarol.com -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
More on ncarol.com
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777
More on ncarol.com
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
- 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
- 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
- Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
- Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
- Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
More on ncarol.com
- New 2025–2026 Energy Rebates: Squeaks Services Explains How to Qualify
- CCHR's New Documentary Prescription for Violence Highlights Overlooked Safety Warnings
- Men's Health Network Announces a New Feature to Support the Well-Being of Men When and Where They Are through Text Alerts
- Comp-U-Floor Unveils Powerful New Commercial Module
- Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777
More on ncarol.com
- How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
- Tax Fears and Political Volatility Drive Wealthy UK Residents to Consider Leaving, La Vida Survey Shows
- Titan Steel Buildings Expands Nationwide to Deliver Large Steel Warehouses and Industrial Facilities
- Marry Me Marinara Announces New Gourmet Pasta Sauce - Bringing Restaurant Quality to Home Kitchens
- Kaltra Removes Size Barriers for Microchannel Coils with Fully Integrated Large-MCHE Production
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
Source: Juventix Regenerative Medical, LLC
Filed Under: Health
0 Comments
Latest on ncarol.com
- Sustainable Santa Returns to Old Sacramento
- Upcoming Launch of Retail Crypto Cloud Mining Platform with Daily Rewards in a Transparent Revenue-Share Model: iMD Companies, Inc. Stock Symbol: ICBU
- BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
- CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
- COHN Named Colorado State-Approved Vendor for Advertising & Marketing Services
- The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think
- RTC Communications Preliminarily Awarded $3.1 Million Federal BEAD Grant to Expand Fiber Broadband in Southern Indiana
- She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
- Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand
- 38 States Complete. 12 States Remain. California Man enters North Carolina on Historic Quest to Cross All 50 States on Foot
- IDCXS Exchange Founder Travels to Angola for Strategic Cooperation Talks
- 2026 NBA Mock Draft: New Wave of Franchise Talent Emerges in Early Lottery Projections
- Bad Bunny Leads 2026 Grammys Album of the Year Odds, Lady Gaga Emerges as Top Challenger
- Metro Detroit teen Lola Winters turns viral TikTok fame into a sold-out clothing brand
- ReedSmith® Celebrates Innovative Founders at TCVN's Survivor™ XII at SoCal Startup Day
- The global race for next-gen precious metals recovery is accelerating: $AABB is positioning itself with it's Revolutionary rGO Gold Recovery System
- NorthSky Celebrates One-Year Anniversary
- Free At Last Bail Bonds Gives Back Through Major Holiday Food Distribution Efforts Across Metro Atlanta
- Discover Elevated Living - Preview the Stunning New Townhome Collection
- TownePlace Suites Prescott Valley, AZ Opens



